156 related articles for article (PubMed ID: 10647910)
1. Extensive metabolism of the flavonoid chrysin by human Caco-2 and Hep G2 cells.
Galijatovic A; Otake Y; Walle UK; Walle T
Xenobiotica; 1999 Dec; 29(12):1241-56. PubMed ID: 10647910
[TBL] [Abstract][Full Text] [Related]
2. Transport of the flavonoid chrysin and its conjugated metabolites by the human intestinal cell line Caco-2.
Walle UK; Galijatovic A; Walle T
Biochem Pharmacol; 1999 Aug; 58(3):431-8. PubMed ID: 10424761
[TBL] [Abstract][Full Text] [Related]
3. Glucuronidation and sulfation of the tea flavonoid (-)-epicatechin by the human and rat enzymes.
Vaidyanathan JB; Walle T
Drug Metab Dispos; 2002 Aug; 30(8):897-903. PubMed ID: 12124307
[TBL] [Abstract][Full Text] [Related]
4. Flavonoids, potent inhibitors of the human P-form phenolsulfotransferase. Potential role in drug metabolism and chemoprevention.
Eaton EA; Walle UK; Lewis AJ; Hudson T; Wilson AA; Walle T
Drug Metab Dispos; 1996 Feb; 24(2):232-7. PubMed ID: 8742236
[TBL] [Abstract][Full Text] [Related]
5. Disposition and metabolism of the flavonoid chrysin in normal volunteers.
Walle T; Otake Y; Brubaker JA; Walle UK; Halushka PV
Br J Clin Pharmacol; 2001 Feb; 51(2):143-6. PubMed ID: 11259985
[TBL] [Abstract][Full Text] [Related]
6. CYP1A1 and CYP3A4 modulation by dietary flavonoids in human intestinal Caco-2 cells.
Sergent T; Dupont I; Van der Heiden E; Scippo ML; Pussemier L; Larondelle Y; Schneider YJ
Toxicol Lett; 2009 Dec; 191(2-3):216-22. PubMed ID: 19766177
[TBL] [Abstract][Full Text] [Related]
7. Induction of human UDP-glucuronosyltransferase UGT1A1 by flavonoids-structural requirements.
Walle UK; Walle T
Drug Metab Dispos; 2002 May; 30(5):564-9. PubMed ID: 11950788
[TBL] [Abstract][Full Text] [Related]
8. Metabolites of galangin by 2,3,7,8-tetrachlorodibenzo-p-dioxin-inducible cytochrome P450 1A1 in human intestinal epithelial Caco-2 cells and their antagonistic activity toward aryl hydrocarbon receptor.
Hamada M; Satsu H; Ashida H; Sugita-Konishi Y; Shimizu M
J Agric Food Chem; 2010 Jul; 58(13):8111-8. PubMed ID: 20550209
[TBL] [Abstract][Full Text] [Related]
9. Differential UGT1A1 induction by chrysin in primary human hepatocytes and HepG2 Cells.
Smith CM; Graham RA; Krol WL; Silver IS; Negishi M; Wang H; Lecluyse EL
J Pharmacol Exp Ther; 2005 Dec; 315(3):1256-64. PubMed ID: 16135700
[TBL] [Abstract][Full Text] [Related]
10. Methylated flavonoids have greatly improved intestinal absorption and metabolic stability.
Wen X; Walle T
Drug Metab Dispos; 2006 Oct; 34(10):1786-92. PubMed ID: 16868069
[TBL] [Abstract][Full Text] [Related]
11. Induction of UDP-glucuronosyltransferase by the flavonoids chrysin and quercetin in Caco-2 cells.
Galijatovic A; Walle UK; Walle T
Pharm Res; 2000 Jan; 17(1):21-6. PubMed ID: 10714603
[TBL] [Abstract][Full Text] [Related]
12. Variable sulfation of dietary polyphenols by recombinant human sulfotransferase (SULT) 1A1 genetic variants and SULT1E1.
Ung D; Nagar S
Drug Metab Dispos; 2007 May; 35(5):740-6. PubMed ID: 17293380
[TBL] [Abstract][Full Text] [Related]
13. Hep G2 cell line as a human model for sulphate conjugation of drugs.
Shwed JA; Walle UK; Walle T
Xenobiotica; 1992 Aug; 22(8):973-82. PubMed ID: 1329363
[TBL] [Abstract][Full Text] [Related]
14. Determination of pharmacokinetics of chrysin and its conjugates in wild-type FVB and Bcrp1 knockout mice using a validated LC-MS/MS method.
Ge S; Gao S; Yin T; Hu M
J Agric Food Chem; 2015 Mar; 63(11):2902-10. PubMed ID: 25715997
[TBL] [Abstract][Full Text] [Related]
15. Metabolism of flavonoids via enteric recycling: role of intestinal disposition.
Chen J; Lin H; Hu M
J Pharmacol Exp Ther; 2003 Mar; 304(3):1228-35. PubMed ID: 12604700
[TBL] [Abstract][Full Text] [Related]
16. Induction of UDP-glucuronosyltransferase UGT1A1 by the flavonoid chrysin in the human hepatoma cell line hep G2.
Walle T; Otake Y; Galijatovic A; Ritter JK; Walle UK
Drug Metab Dispos; 2000 Sep; 28(9):1077-82. PubMed ID: 10950852
[TBL] [Abstract][Full Text] [Related]
17. Absorption and metabolism of flavonoids in the caco-2 cell culture model and a perused rat intestinal model.
Liu Y; Hu M
Drug Metab Dispos; 2002 Apr; 30(4):370-7. PubMed ID: 11901089
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of glucuronidation and oxidative metabolism of buprenorphine using GRAS compounds or dietary constituents/supplements: in vitro proof of concept.
Maharao NV; Joshi AA; Gerk PM
Biopharm Drug Dispos; 2017 Mar; 38(2):139-154. PubMed ID: 27925249
[TBL] [Abstract][Full Text] [Related]
19. Individual and interactive effects of apigenin analogs on G2/M cell-cycle arrest in human colon carcinoma cell lines.
Wang W; VanAlstyne PC; Irons KA; Chen S; Stewart JW; Birt DF
Nutr Cancer; 2004; 48(1):106-14. PubMed ID: 15203384
[TBL] [Abstract][Full Text] [Related]
20. Sodium Oleate-Based Nanoemulsion Enhances Oral Absorption of Chrysin through Inhibition of UGT-Mediated Metabolism.
Dong D; Quan E; Yuan X; Xie Q; Li Z; Wu B
Mol Pharm; 2017 Sep; 14(9):2864-2874. PubMed ID: 27983856
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
